Creating a 3D printed radiation system for small animals
Development of a 3D printed small animal intensity modulated radiation system
This study is working on a new type of radiation therapy for small animals like mice, which are often used in research, to make treatments more precise and effective, helping scientists get better results that could apply to humans.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Los Angeles NIH-funded |
| Lab location | 1 site (Los Angeles, United States) |
| Project ID | NIH-11283737 on NIH RePORTER |
What this research studies
This research focuses on developing a new radiation therapy system specifically designed for small animal models, such as mice, which are commonly used in biomedical research. The goal is to enhance the accuracy and effectiveness of radiation treatments in these models by using advanced techniques similar to those used in human clinical settings. By implementing intensity modulated radiation therapy (IMRT), the researchers aim to improve the reproducibility of preclinical results, making them more relevant for human applications. This innovative approach seeks to bridge the gap between clinical and preclinical radiation therapy methodologies.
Who could benefit from this research
Good fit: Ideal candidates for benefiting from this research include those involved in preclinical studies or those interested in the development of more effective cancer treatments.
Not a fit: Patients who are not involved in preclinical research or who do not have conditions requiring radiation therapy may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective preclinical studies that better predict human responses to radiation therapy.
How similar studies have performed: While the approach of using IMRT in clinical settings has shown success, the application of this technology in small animal models is relatively novel and has not been extensively tested.
Where this research is happening
Los Angeles, United States
- University of California Los Angeles — Los Angeles, United States (Active)
Researchers
- Principal investigator: Wiersma, Rodney — University of California Los Angeles
- Study coordinator: Wiersma, Rodney
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.